The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Zieman
Miriam
M
Department of Obstetrics and Gynecology, Emory University School of Medicine, Atlanta, Georgia 30303, USA. mzieman@emory.edu
D000279:Administration, Cutaneous; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage*; D004338:Drug Combinations; D016503:Drug Delivery Systems; D004967:Estrogens / Q000008:administration & dosage / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000008:administration & dosage*; D005003:Ethisterone / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D009644:Norgestrel / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D010091:Oximes; D011372:Progestins / Q000008:administration & dosage / Q000494:pharmacology
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D004967:Estrogens; D010091:Oximes; D011372:Progestins; D009644:Norgestrel; D004997:Ethinyl Estradiol; C017576:norgestimate; D005003:Ethisterone; C449219:norelgestromin